Streetbeat News

Stock Prices

ENTO

Entero Therapeutics has filed with the SEC for a shelf offering of up to 3.5 million shares of common stock by selling stockholders.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:21 pm

NYMT

New York Mortgage Trust (NYMT) has filed for a mixed shelf offering of up to $300 million, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:18 pm

GRI

GRI Bio has increased the amount of common stock it plans to sell under its sales agreement to an offering price of up to $2.6 million, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:18 pm

NDAQ

Nasdaq shares are trading lower following the announcement of a secondary offering of 41,604,207 shares of common stock.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:17 pm

KO

Wealthy investors have taken a bearish stance on Coca-Cola (NYSE:KO), as evidenced by recent options trades tracked by Benzinga. The sentiment is split with 50% bearish and 20% bullish. Analysts maintain positive ratings with an average price target of $72.0.

Portfolio Pulse from Benzinga Insights

July 26, 2024 | 8:16 pm

MS

Morgan Stanley's options trading shows a bearish sentiment among significant investors, with 47% of trades being bearish and 36% bullish. The trading activity suggests a price target range of $55.0 to $110.0. The stock is currently trading at $104.19 with a slight increase of 0.61%.

Portfolio Pulse from Benzinga Insights

July 26, 2024 | 8:15 pm

CGTX

Cognition Therapeutics, Inc. (NASDAQ:CGTX) will host an investor webcast on July 29, 2024, to discuss results from the Phase 2 SHINE study of CT1812 in mild-to-moderate Alzheimer's disease. The webcast will cover clinical efficacy, safety, and biomarker findings. Results will also be presented at the Alzheimer's Association's International Conference.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:13 pm

NDAQ

Nasdaq, Inc. (NDAQ) announced a secondary public offering of 41,604,207 shares held by Argus Seller, LP, and a share repurchase agreement to buy 1.2M shares for up to $120M. The repurchase is part of Nasdaq's existing program and will be funded by cash and borrowings.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:12 pm

RVSN

Rail Vision Ltd. (NASDAQ:RVSN) received a notification from Nasdaq indicating non-compliance with the minimum bid price requirement, as its share price has been below $1.00 for the last 30 consecutive business days.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:10 pm

RNAZ

TransCode Therapeutics' recent SEC 13G filing reveals that 3i, LP has reported a 9.9% stake in the company as of July 23, 2024.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:10 pm